1. Home
  2. LEE vs ENLV Comparison

LEE vs ENLV Comparison

Compare LEE & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$5.24

Market Cap

31.3M

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$1.00

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEE
ENLV
Founded
1890
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.3M
26.6M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
LEE
ENLV
Price
$5.24
$1.00
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
88.4K
461.1K
Earning Date
02-05-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$562,341,000.00
N/A
Revenue This Year
$5.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$0.66
52 Week High
$15.15
$2.10

Technical Indicators

Market Signals
Indicator
LEE
ENLV
Relative Strength Index (RSI) 66.83 60.64
Support Level $4.60 $0.85
Resistance Level $5.33 $1.03
Average True Range (ATR) 0.43 0.07
MACD 0.07 0.03
Stochastic Oscillator 78.74 91.22

Price Performance

Historical Comparison
LEE
ENLV

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: